Topic: radioisotopes

The Nuclear Chemistry Group at RIKEN’s Nishina Center for Accelerator-Based Science seeks one postdoctoral researcher, research scientist or Technical Staff I. The AMED cancer research project develops production and use of radioisotopes with the heavy-ion accelerators at the RIKEN RI Beam Factory. Researchers will develop isotope production and utilization techniques, investigate applications, distribute radioisotopes and maintain production equipment and hot laboratories. Technical staff will support production, quality evaluation and distribution, manage radioisotopes and chemicals, and sup

Monash Biomedical Imaging is part of the new $71.2 million Australian Precision Medicine Enterprise (APME) facility, which will deliver large-scale development and manufacturing of precision medicines and theranostic radiopharmaceuticals for industry and research. A key feature of the APME project is a high-energy cyclotron with multiple production clean rooms, which will be located on the Monash Biomedical Imaging (MBI) site in Clayton. This strategic co-location will facilitate radiochemistry, PET and SPECT research and clinical use of theranostic (therapeutic and diagnostic) radioisotopes p

Molecular imaging using Positron Emission Tomography (PET) has become a major biomedical imaging technology. Its application towards characterisation of biochemical processes in disease could enable early detection and diagnosis, development of novel therapies and treatment evaluation. The technology is underpinned by the use of imaging probes radiolabelled with short-lived radioisotopes which can be specific and selective for biological targets in vivo e.g. markers for receptors, protein deposits, enzymes and metabolism. My talk will focus on the increasing development and application of PET